Clinical Trial

Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.
Trial Details
NCT Number NCT07742683
Lead Sponsor Peking Union Medical College
Collaborators: Beijing Center for Disease Prevention and Control, Hainan Provincial Center for Disease Control and Prevention, Yichang Center for Disease Control and Prevention, China
Conditions Tuberculosis (TB)
Enrollment 496 participants
Start Date 2026-10
Primary Completion 2027-09 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-03